Invictus RG’s Teladoc Health TDOC Stock Holding History

Invictus RG’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-4,044	Closed	-$627K	–	24
2020 Q1	$627K	Buy	+4,044	New	+$470K	2.25%	18
2018 Q3	–	Sell	-5,479	Closed	-$318K	–	256
2018 Q2	$318K	Buy	+5,479	New	+$268K	0.27%	105

Other funds holding TDOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invictus RG's TDOC Position: Q2 2020 in Review

Invictus RG sold out of Teladoc Health (TDOC) in Q2 2020, closing a stake of 4,044 shares — an estimated $627K sold.

Invictus RG first reported a position in TDOC in Q2 2018 and held it in 2 quarters. The position peaked at $627K in Q1 2020. 670 funds tracked by Wall St. Rank hold TDOC as of Q2 2020.

Invictus RG reported no remaining Teladoc Health position as of Q2 2020 after selling out during the quarter.
Invictus RG sold 4,044 Teladoc Health shares in Q2 2020, an estimated $627K.
Invictus RG first reported a position in Teladoc Health in Q2 2018 and held it in 2 quarters.
Invictus RG's Teladoc Health position peaked at $627K in Q1 2020.
670 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2020.

Based on Invictus RG's 13F filing for Q2 2020, filed 14 Aug 2020.